{{Rsnum
|rsid=10922438
|Chromosome=1
|position=198500032
|Orientation=plus
|GMAF=0.09412
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 15.3 | 84.7
| HCB | 0.8 | 15.0 | 84.2
| JPT | 0.9 | 19.8 | 79.3
| YRI | 0.0 | 20.3 | 79.7
| ASW | 1.8 | 17.5 | 80.7
| CHB | 0.8 | 15.0 | 84.2
| CHD | 1.9 | 9.4 | 88.7
| GIH | 8.0 | 40.0 | 52.0
| LWK | 0.9 | 16.0 | 83.0
| MEX | 1.8 | 30.4 | 67.9
| MKK | 1.9 | 11.6 | 86.5
| TSI | 0.0 | 12.0 | 88.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=6E-6
  |OR=2.30
  |ORtxt=[1.608-3.293]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}